Randall E. Kaye

2023

In 2023, Randall E. Kaye earned a total compensation of $1.2M as Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$228,690
Option Awards$443,113
Salary$472,500
Other$16,764
Total$1,161,067

Kaye received $472.5K in salary, accounting for 41% of the total pay in 2023.

Kaye also received $228.7K in non-equity incentive plan, $443.1K in option awards and $16.8K in other compensation.

Rankings

In 2023, Randall E. Kaye's compensation ranked 1,038th out of 2,918 executives tracked by ExecPay. In other words, Kaye earned more than 64.4% of executives.

ClassificationRankingPercentile
All
1,038
out of 2,918
64th
Division
Manufacturing
621
out of 1,608
61st
Major group
Chemicals And Allied Products
428
out of 901
53rd
Industry group
Drugs
417
out of 864
52nd
Industry
Pharmaceutical Preparations
285
out of 622
54th
Source: SEC filing on April 12, 2024.

Kaye's colleagues

We found two more compensation records of executives who worked with Randall E. Kaye at Longboard Pharmaceuticals in 2023.

2023

Kevin Lind

Longboard Pharmaceuticals

Chief Executive Officer

2023

Brandi Roberts

Longboard Pharmaceuticals

Chief Financial Officer

News

You may also like